Tariffs should not influence decisions at Indian drug companies, Cipla's top executive said on Friday, as the industry braces ...
If drug tariffs don’t work, they could result in higher prices for American patients and increase drug shortages. Testing ...
The US relies heavily on Indian generic medicines, with nearly half of all generic drugs consumed in the US originating from ...
The Indian Pharmaceutical Alliance (IPA) has proposed reducing the import duty on pharma products from the US to zero.
New Delhi: Cancer patients facing prohibitive treatment costs in India can hope for relief: the nation's top drugmakers have ...
Dilip Shanghvi, chairman of India's largest drugmaker Sun Pharma, told an industry gathering last week that his company sells ...
Indian pharmaceutical industry leaders indicate that proposed US tariffs on pharmaceutical exports may lead to increased drug ...
Indian pharmaceutical companies may have units abroad as part of 'distributed manufacturing' across various locations, ...
The pharma sector export data for fourth quarter has been released. According to Phillip Capital, the latest export data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results